PTC
AXSM icon

Private Trust Company’s Axsome Therapeutics AXSM Stock Holding History

Private Trust Company’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.5K Buy
51
+10
+24% +$2.17K ﹤0.01% 1986
2026
Q1 		$6.93K Hold
41
– – ﹤0.01% 2093
2025
Q4 		$7.49K Hold
41
– – ﹤0.01% 2039
2025
Q3 		$4.98K Hold
41
– – ﹤0.01% 2154
2025
Q2 		$4.28K Hold
41
– – ﹤0.01% 2106
2025
Q1 		$4.78K Sell
41
-8
-16% -$911 ﹤0.01% 2049
2024
Q4 		$4.15K Buy
49
+11
+29% +$1.01K ﹤0.01% 2042
2024
Q3 		$3.42K Hold
38
– – ﹤0.01% 2065
2024
Q2 		$3.06K Sell
38
-4
-10% -$296 ﹤0.01% 2074
2024
Q1 		$3.35K Buy
+42
New +$3.52K ﹤0.01% 2025

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Private Trust Company's AXSM Position: Q2 2026 in Review

Private Trust Company increased its Axsome Therapeutics (AXSM) stake by 24% in Q2 2026, buying an estimated $2.17K and bringing the position to 51 shares worth $12.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1986.

Private Trust Company first reported a position in AXSM in Q1 2024 and has held it in 10 quarters since. 504 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Private Trust Company held 51 shares of Axsome Therapeutics worth $12.5K as of Q2 2026.
  • Private Trust Company bought 10 Axsome Therapeutics shares in Q2 2026, an estimated $2.17K.
  • Axsome Therapeutics made up ﹤0.01% of Private Trust Company's portfolio in Q2 2026, its #1986 holding.
  • Private Trust Company first reported a position in Axsome Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • 504 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Private Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.